~~<i id='62366AE294'><strike id='62366AE294'><tt id='62366AE294'><pre id='62366AE294'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：comprehensive 2025-09-30 17:28:16 - browse：81246

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Roche to buy Carmot Therapeutics, developer of obesity drugs

entertainment

knowledge

hotspot

knowledge

focus

hotspot

CourtesyRyanPickeringPROVIDENCE–InlateAugust,Dr.JamesE.FanalewastrudgingthroughtheFalmouthRoadRace—w

WSS

Patients' immediate access to test results puts radiologists in a bind

Teach medical students about patients with intellectual disabilities

Radiology is caught between AI's potential and concern for patients

Experimental asthma app from Apple and Anthem shows promise

What is STAT's opinion section for?

Study suggests Covid rebound is far more common with Paxlovid than without

Wikipedia

fashion

entertainment

Apple is now the first public company to be valued at $3 trillion

Healthy food access boosts outcomes in two studies

Duchenne breakthrough therapy leaves behind pioneering families

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Medical leaders decry Supreme Court decision on affirmative action

How state and local governments are sidelining science

How to save PrEP access — and even expand it

Experimental asthma app from Apple and Anthem shows promise

Trump demands the U.S. pay no more for drugs than other countries … again

White House drug czar issues call for 'recovery

knowledge

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

How state and local governments are sidelining science

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Congenital heart disease patients face new threat of heart failure

Study suggests Covid rebound is far more common with Paxlovid than without

What causes an itch? Researchers may have solved the mystery

hotspot

knowledge

focus

hotspot